Response: Association between Diabetic Polyneuropathy and Chronic Complications in Type 2 Diabetic Patients (Diabetes Metab J 2011;35:390-6)

Response: Association between Diabetic Polyneuropathy and Chronic Complications in Type 2 Diabetic Patients (Diabetes Metab J 2011;35:390-6)

Bibliographic Details
Main Authors:	Chung, Jin Ook, Cho, Dong Hyeok, Chung, Dong Jin, Chung, Min Young
Format:	Online
Language:	English
Published:	Korean Diabetes Association 2011
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253976/

Similar Items

Letter: Diabetic Polyneuropathy and Cardiovascular Complications in Type 2 Diabetic Patients (Diabetes Metab J 2011;35:390-6)
by: Ko, Sun-Hye, et al.
Published: (2011)

Association between Diabetic Polyneuropathy and Cardiovascular Complications in Type 2 Diabetic Patients
by: Chung, Jin Ook, et al.
Published: (2011)

Response: The Effect of an Angiotensin Receptor Blocker on Arterial Stiffness in Type 2 Diabetes Mellitus Patients with Hypertension (Diabetes Metab J 2011;35:236-42)
by: Kim, Ji Hyun, et al.
Published: (2011)

Response: Predictive Clinical Parameters for the Therapeutic Efficacy of Sitagliptin in Korean Type 2 Diabetes Mellitus (Diabetes Metab J 2011;35:159-65)
by: Kim, Soon Ae, et al.
Published: (2011)

Letter: Predictive Clinical Parameters for the Therapeutic Efficacy of Sitagliptin in Korean Type 2 Diabetes Mellitus (Diabetes Metab J 2011;35:159-65)
by: Oh, Jee-Young
Published: (2011)

Letter: The Effect of an Angiotensin Receptor Blocker on Arterial Stiffness in Type 2 Diabetes Mellitus Patients with Hypertension (Diabetes Metab J 2011;35:236-42)
by: Kim, Chul-Hee
Published: (2011)

Letter: Basal C-peptide Level as a Surrogate Marker of Subclinical Atherosclerosis in Type 2 Diabetes Patients (Diabetes Metab J 2011;35:41-9)
by: Lee, Min Suk, et al.
Published: (2011)

Response: Basal C-peptide Level as a Surrogate Marker of Subclinical Atherosclerosis in Type 2 Diabetic Patients (Diabetes Metab J 2011;35:41-9)
by: Kim, Sung-Tae, et al.
Published: (2011)

Letter: The Prevalence of Peripheral Arterial Disease in Korean Patients with Type 2 Diabetes Mellitus Attending a University Hospital (Diabetes Metab J 2011;35:543-50)
by: Kim, Won Jun, et al.
Published: (2011)

Response: The Prevalence of Peripheral Arterial Disease in Korean Patients with Type 2 Diabetes Mellitus Attending a University Hospital (Diabetes Metab J 2011;35:543-50)
by: Yu, Ji Hee, et al.
Published: (2012)

Letter: Higher Glycated Hemoglobin Level Is Associated with Increased Risk of Ischemic Stroke in Non-Diabetic Korean Male Adults (Diabetes Metab J 2011;35:551-7)
by: Lee, Seok Hong, et al.
Published: (2012)

Response: Higher Glycated Hemoglobin Level Is Associated with Increased Risk for Ischemic Stroke in Non-Diabetic Korean Male Adults (Diabetes Metab J 2011;35:551-7)
by: Oh, Hyung Geun, et al.
Published: (2012)

Associations between Hemoglobin Concentrations and the Clinical Characteristics of Patients with Type 2 Diabetes
by: Chung, Jin Ook, et al.
Published: (2012)

Associations among Body Mass Index, Insulin Resistance, and Pancreatic β-Cell Function in Korean Patients with New-Onset Type 2 Diabetes
by: Chung, Jin Ook, et al.
Published: (2012)

Response: Clinical Marker of Platelet Hyperreactivity in Diabetes Mellitus (Diabetes Metab J 2013;37:423-8)
by: Kim, Jin Hwa, et al.
Published: (2014)

Prevalence and determinants of diabetic polyneuropathy and diabetic foot complications in a specialized clinic
by: de Almeida, Marcos Oliveira Pires, et al.
Published: (2015)

Letter: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8)
by: Li, Sheyu, et al.
Published: (2013)

Response: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8)
by: Kim, Kwang Joon, et al.
Published: (2013)

Letter: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8)
by: Kim, Sang-Yong
Published: (2012)

Response: The Risk of Bladder Cancer in Korean Diabetic Subjects Treated with Pioglitazone (Diabetes Metab J 2012;36:371-8)
by: Song, Sun Ok, et al.
Published: (2012)

Letter: Clinical Marker of Platelet Hyperreactivity in Diabetes Mellitus (Diabetes Metab J 2013;37:423-8)
by: Beyan, Cengiz, et al.
Published: (2014)

Letter: Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2016;40:240-7)
by: Kim, Jin Hwa
Published: (2016)

Update on the management of diabetic polyneuropathies
by: Shakher, Jayadave, et al.
Published: (2011)

Letter: Diabetic Retinopathy and Endothelial Dysfunction in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2013;37:262-9)
by: Son, Seok Man
Published: (2013)

Response: Diabetic Retinopathy and Endothelial Dysfunction in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2013;37:262-9)
by: Yun, Jae-Seung, et al.
Published: (2013)

Conduction Slowing in Diabetic Sensorimotor Polyneuropathy
by: Dunnigan, Samantha K., et al.
Published: (2013)

Pathways in the Diagnosis and Management of Diabetic Polyneuropathy
by: Kaku, Michelle, et al.
Published: (2015)

Letter: Prevalence and Correlates of Disordered Sleep in Southeast Asian Indians with Type 2 Diabetes (Diabetes Metab J 2012;36:70-6)
by: Kawada, Tomoyuki
Published: (2012)

Response: Prevalence and Correlates of Disordered Sleep in Southeast Asian Indians with Type 2 Diabetes (Diabetes Metab J 2012;36:70-6)
by: Rajendran, Amarabalan, et al.
Published: (2012)

The Prevalence of Diabetic Complications in Korea
by: Lee, Tai Hee, et al.
Published: (1987)

Response: Prevalence and Risk Factors of Gastroesophageal Reflux Disease in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2016;40:297-307)
by: Ha, Jun Ouk, et al.
Published: (2016)

Letter: Prevalence and Risk Factors of Gastroesophageal Reflux Disease in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2016;40:297-307)
by: Yi, Dongwon
Published: (2016)

Response: Effects of Rebamipide on Gastrointestinal Symptoms in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2016;40:240-7)
by: Park, Sejeong, et al.
Published: (2016)

Letter: Cardiovascular Disease Predicts Severe Hypoglycemia in Patients with Type 2 Diabetes (Diabetes Metab J 2015;39:498-506)
by: Kim, Mi-Kyung
Published: (2016)

Response: Cardiovascular Disease Predicts Severe Hypoglycemia in Patients with Type 2 Diabetes (Diabetes Metab J 2015;39:498-506)
by: Yun, Jae-Seung, et al.
Published: (2016)

Letter: Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2015;39:342-7)
by: Kim, Ye An
Published: (2015)

Response: Predictive Factors for Efficacy of Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes Mellitus (Diabetes Metab J 2015;39:342-7)
by: Yagi, Shusuke, et al.
Published: (2015)

Letter: The Effect of DPP-4 Inhibitors on Metabolic Parameters in Patients with Type 2 Diabetes (Diabetes Metab J 2014;38:211-9)
by: Lee, Seung-Hwan
Published: (2014)

Response: The Effect of DPP-4 Inhibitors on Metabolic Parameters in Patients with Type 2 Diabetes (Diabetes Metab J 2014;38:211-9)
by: Choe, EunYeong, et al.
Published: (2014)

Comparison of diabetes patients with “demyelinating” diabetic sensorimotor polyneuropathy to those diagnosed with CIDP
by: Dunnigan, Samantha K, et al.
Published: (2013)